Family history and outcome of young patients with breast cancer in the UK (POSH study)
Family history and outcome of young patients with breast cancer in the UK (POSH study)
BACKGROUND: Young patients presenting to surgical clinics with breast cancer are usually aware of their family history and frequently believe that a positive family history may adversely affect their prognosis. Tumour pathology and outcomes were compared in young British patients with breast cancer with and without a family history of breast cancer.
METHODS: Prospective Outcomes in Sporadic versus Hereditary breast cancer (POSH) is a large prospective cohort study of women aged less than 41 years with breast cancer diagnosed and treated in the UK using modern oncological management. Personal characteristics,?tumour pathology, treatment and family history of breast/ovarian cancer were recorded. Follow-up data were collected annually.
RESULTS: Family history data were available for 2850 patients. No family history was reported by 65·9 per cent, and 34·1 per cent reported breast/ovarian cancer in at least one first- or second-degree relative. Patients with a family history were more likely to have grade 3 tumours (63·3 versus 58·9 per cent) and less likely to have human epidermal growth factor receptor 2-positive tumours (24·7 versus 28·8 per cent) than those with no family history. In multivariable analyses,?there were no significant differences in distant disease-free intervals for patients with versus those without a family history, either for the whole cohort (hazard ratio (HR) 0·89, 95 per cent c.i. 0·76 to 1·03; P = 0·120) or when stratified by oestrogen receptor (ER) status (ER-negative: HR 0·80, 0·62 to 1·04, P = 0·101; ER-positive: HR 0·95, 0·78 to 1·15, P = 0·589).
CONCLUSION: Young British patients presenting to breast surgical clinics with a positive family history can be reassured that this is not a significant independent risk factor for breast cancer outcome
924-935
Eccles, B.K.
f75cacaf-2acf-429a-8873-8451ffc117c4
Copson, E.R.
a94cdbd6-f6e2-429d-a7c0-462c7da0e92b
Cutress, R.
68ae4f86-e8cf-411f-a335-cdba51797406
Maishman, T.
cf4259a4-0eef-4975-9c9d-a2c3d594f989
Altman, D.G.
c8c0dc66-dd65-4b27-bbce-40bc744536ff
Simmonds, P.
27d4c068-e352-4cbf-9899-771893788ade
Gerty, S.
b2013815-27c9-4a7d-ad42-071f60a8000f
Durcan, L.
bd059b41-9e77-4afe-b271-9ac4c91a05c6
Stanton, L.
8b827763-d839-4b4b-bbf2-358a84110294
Eccles, D.M.
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23
July 2015
Eccles, B.K.
f75cacaf-2acf-429a-8873-8451ffc117c4
Copson, E.R.
a94cdbd6-f6e2-429d-a7c0-462c7da0e92b
Cutress, R.
68ae4f86-e8cf-411f-a335-cdba51797406
Maishman, T.
cf4259a4-0eef-4975-9c9d-a2c3d594f989
Altman, D.G.
c8c0dc66-dd65-4b27-bbce-40bc744536ff
Simmonds, P.
27d4c068-e352-4cbf-9899-771893788ade
Gerty, S.
b2013815-27c9-4a7d-ad42-071f60a8000f
Durcan, L.
bd059b41-9e77-4afe-b271-9ac4c91a05c6
Stanton, L.
8b827763-d839-4b4b-bbf2-358a84110294
Eccles, D.M.
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23
Eccles, B.K., Copson, E.R., Cutress, R., Maishman, T., Altman, D.G., Simmonds, P., Gerty, S., Durcan, L., Stanton, L. and Eccles, D.M.
(2015)
Family history and outcome of young patients with breast cancer in the UK (POSH study).
British Journal of Surgery, 102 (8), .
(doi:10.1002/bjs.9816).
(PMID:25989914)
Abstract
BACKGROUND: Young patients presenting to surgical clinics with breast cancer are usually aware of their family history and frequently believe that a positive family history may adversely affect their prognosis. Tumour pathology and outcomes were compared in young British patients with breast cancer with and without a family history of breast cancer.
METHODS: Prospective Outcomes in Sporadic versus Hereditary breast cancer (POSH) is a large prospective cohort study of women aged less than 41 years with breast cancer diagnosed and treated in the UK using modern oncological management. Personal characteristics,?tumour pathology, treatment and family history of breast/ovarian cancer were recorded. Follow-up data were collected annually.
RESULTS: Family history data were available for 2850 patients. No family history was reported by 65·9 per cent, and 34·1 per cent reported breast/ovarian cancer in at least one first- or second-degree relative. Patients with a family history were more likely to have grade 3 tumours (63·3 versus 58·9 per cent) and less likely to have human epidermal growth factor receptor 2-positive tumours (24·7 versus 28·8 per cent) than those with no family history. In multivariable analyses,?there were no significant differences in distant disease-free intervals for patients with versus those without a family history, either for the whole cohort (hazard ratio (HR) 0·89, 95 per cent c.i. 0·76 to 1·03; P = 0·120) or when stratified by oestrogen receptor (ER) status (ER-negative: HR 0·80, 0·62 to 1·04, P = 0·101; ER-positive: HR 0·95, 0·78 to 1·15, P = 0·589).
CONCLUSION: Young British patients presenting to breast surgical clinics with a positive family history can be reassured that this is not a significant independent risk factor for breast cancer outcome
This record has no associated files available for download.
More information
Accepted/In Press date: 3 March 2015
e-pub ahead of print date: 20 May 2015
Published date: July 2015
Organisations:
Cancer Sciences, Clinical Trials Unit
Identifiers
Local EPrints ID: 380822
URI: http://eprints.soton.ac.uk/id/eprint/380822
PURE UUID: ea8e17d1-65fd-49c8-89bf-3b175fc8dc5f
Catalogue record
Date deposited: 24 Aug 2015 09:10
Last modified: 15 Mar 2024 03:28
Export record
Altmetrics
Contributors
Author:
B.K. Eccles
Author:
T. Maishman
Author:
D.G. Altman
Author:
P. Simmonds
Author:
S. Gerty
Author:
L. Durcan
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics